Placebo group (n = 14) | B6 group (n = 14) | p value (baseline)a | p value (treat)b | |||
---|---|---|---|---|---|---|
Before | After | Before | After | |||
Plasma PLP (nmol/l)c | 22.8 (15.4–31.5) | 23.6 (15.2–43.0) | 27.0 (20.4–30.9) | 144.5 (84.5–236.7) | <0.0001 | <0.0001 |
Erythrocyte PLP (nmol/l) | 26.0 (20.8–39.4) | 41.6 (28.5–53.7) | 44.6 (37.5–54.0) | 116.4 (65.3–424.7) | 0.623 | 0.002 |
αEAST | 1.88 (1.67–1.99) | 1.85 (1.64–1.96) | 1.80 (1.68–1.93) | 1.33 (1.29–1.40) | 0.001 | <0.0001 |
ΔtHcy (μmol/l)c | 19.2 (15.0–27.5) | 17.9 (13.0–25.8) | 24.9 (16.4–35.9) | 19.0 (15.5–28.7) | <0.0001 | 0.086 |
Post-load XA (μmol/24 h)c | 173 (132–243) | 137 (103–354) | 183 (30–653) | 102 (39–371) | 0.001 | 0.042 |
4-PA (μg/24 h) | 0.7 (0.5–1.2) | 0.8 (0.5–170) | 0.8 (0.5–2.0) | 4.2 (0.8–12.8) | 0.338 | <0.0001 |